This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sambol, S. P.
Right arrow Articles by Johnson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sambol, S. P.
Right arrow Articles by Johnson, S.

 Previous Article  |  Next Article 

Infection and Immunity, October 2000, p. 5480-5487, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Toxin Gene Analysis of a Variant Strain of Clostridium difficile That Causes Human Clinical Disease

Susan P. Sambol,1 Michelle M. Merrigan,1 David Lyerly,2 Dale N. Gerding,1 and Stuart Johnson1,*

Infectious Disease Section, Department of Medicine, Veterans Affairs Chicago Health Care System, Lakeside Division, and Northwestern University Medical School, Chicago, Illinois,1 and TechLab, Inc., Blacksburg, Virginia2

Received 7 February 2000/Returned for modification 17 April 2000/Accepted 28 June 2000

A toxin variant strain of Clostridium difficile was isolated from two patients with C. difficile-associated disease (CDAD), one of whom died from extensive pseudomembranous colitis. This strain, identified by restriction endonuclease analysis (REA) as type CF2, was not detected by an immunoassay for C. difficile toxin A. Culture supernatants of CF2 failed to elicit significant enterotoxic activity in the rabbit ileal loop assay but did produce atypical cytopathic effects in cell culture assay. Southern hybridization, PCR amplification, and DNA sequence analyses were performed on the toxin A (tcdA) and toxin B (tcdB) genes of type CF2 isolate 5340. Type CF2 5340 tcdA exhibited a 1,821-bp truncation, due to three deletions in the 3' end of the gene, and a point mutation in the 5' end of the gene, resulting in a premature stop codon at tcdA position 139. Type CF2 5340 tcdB exhibited multiple nucleotide base substitutions in the 5' end of the gene compared to tcdB of the standard toxigenic strain VPI 10463. Type CF2 5340 toxin gene nucleotide sequences and deduced amino acid sequences showed a strong resemblance to those of the previously described variant C. difficile strain 1470, a strain reported to have reduced pathogenicity and no association with clinical illness in humans. REA of strain 1470 identified this strain as a distinct type (CF1) within the same REA group as the closely related type CF2. A review of our clinical-isolate collection identified five additional patients infected with type CF2, three of whom had documented CDAD. PCR amplification of the 3' end of tcdA demonstrated identical 1.8-kb deletions in all seven type CF2 isolates. REA type CF2 is a toxin variant strain of C. difficile that retains the ability to cause disease in humans but is not detected in clinical immunoassays for toxin A.

* Corresponding author. Mailing address: VA Chicago Health Care System, Lakeside Division, Medicine Service, 333 East Huron, Chicago, IL 60611. Phone: (312) 640-2193. Fax: (312) 640-2313. E-mail: stu-johnson{at}nwu.edu.

Infection and Immunity, October 2000, p. 5480-5487, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Ho, J. G. S., Greco, A., Rupnik, M., Ng, K. K.-S. (2005). Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl. Acad. Sci. USA 102: 18373-18378 [Abstract] [Full Text]  
  • Voth, D. E., Ballard, J. D. (2005). Clostridium difficile Toxins: Mechanism of Action and Role in Disease. Clin. Microbiol. Rev. 18: 247-263 [Abstract] [Full Text]  
  • Pituch, H., Rupnik, M., Obuch-Woszczatynski, P., Grubesic, A., Meisel-Mikolajczyk, F., Luczak, M. (2005). Detection of binary-toxin genes (cdtA and cdtB) among Clostridium difficile strains isolated from patients with C. difficile-associated diarrhoea (CDAD) in Poland. J Med Microbiol 54: 143-147 [Abstract] [Full Text]  
  • Lemee, L., Dhalluin, A., Testelin, S., Mattrat, M.-A., Maillard, K., Lemeland, J.-F., Pons, J.-L. (2004). Multiplex PCR Targeting tpi (Triose Phosphate Isomerase), tcdA (Toxin A), and tcdB (Toxin B) Genes for Toxigenic Culture of Clostridium difficile. J. Clin. Microbiol. 42: 5710-5714 [Abstract] [Full Text]  
  • Spigaglia, P., Mastrantonio, P. (2004). Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53: 1129-1136 [Abstract] [Full Text]  
  • Geric, B., Rupnik, M., Gerding, D. N., Grabnar, M., Johnson, S. (2004). Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 53: 887-894 [Abstract] [Full Text]  
  • Blake, J. E., Mitsikosta, F., Metcalfe, M. A. (2004). Immunological detection and cytotoxic properties of toxins from toxin A-positive, toxin B-positive Clostridium difficile variants. J Med Microbiol 53: 197-205 [Abstract] [Full Text]  
  • Geric, B., Johnson, S., Gerding, D. N., Grabnar, M., Rupnik, M. (2003). Frequency of Binary Toxin Genes among Clostridium difficile Strains That Do Not Produce Large Clostridial Toxins. J. Clin. Microbiol. 41: 5227-5232 [Abstract] [Full Text]  
  • Johnson, S., Sambol, S. P., Brazier, J. S., Delmee, M., Avesani, V., Merrigan, M. M., Gerding, D. N. (2003). International Typing Study of Toxin A-Negative, Toxin B-Positive Clostridium difficile Variants. J. Clin. Microbiol. 41: 1543-1547 [Abstract] [Full Text]  
  • Aboudola, S., Kotloff, K. L., Kyne, L., Warny, M., Kelly, E. C., Sougioultzis, S., Giannasca, P. J., Monath, T. P., Kelly, C. P. (2003). Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A. Infect. Immun. 71: 1608-1610 [Abstract] [Full Text]  
  • Rupnik, M., Kato, N., Grabnar, M., Kato, H. (2003). New Types of Toxin A-Negative, Toxin B-Positive Strains among Clostridium difficile Isolates from Asia. J. Clin. Microbiol. 41: 1118-1125 [Abstract] [Full Text]  
  • Spigaglia, P., Mastrantonio, P. (2002). Molecular Analysis of the Pathogenicity Locus and Polymorphism in the Putative Negative Regulator of Toxin Production (TcdC) among Clostridium difficile Clinical Isolates. J. Clin. Microbiol. 40: 3470-3475 [Abstract] [Full Text]  
  • Guilbault, C., Labbe, A.-C., Poirier, L., Busque, L., Beliveau, C., Laverdiere, M. (2002). Development and Evaluation of a PCR Method for Detection of the Clostridium difficile Toxin B Gene in Stool Specimens. J. Clin. Microbiol. 40: 2288-2290 [Abstract] [Full Text]  
  • Johnson, S., Kent, S. A., O'Leary, K. J., Merrigan, M. M., Sambol, S. P., Peterson, L. R., Gerding, D. N. (2001). Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay. ANN INTERN MED 135: 434-438 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»